H. Bando

Biased Discordance of KRAS Mutation Detection in Archived Colorectal Cancer Specimens Between the ARMS-Scorpion Method and Direct Sequencing

H. Bando, Katsuya Tsuchihara, Takashi Yoshino et al. · Japanese Journal of Clinical Oncology · 2010 · 21 citations · Full text

Medicine, Oncology, Pathology +17

Clinical Outcome of Japanese Metastatic Colorectal Cancer Patients Harbouring the KRAS p.G13D Mutation Treated with Cetuximab + Irinotecan

H. Bando, T. Yoshino, Satoshi Yuki et al. · Japanese Journal of Clinical Oncology · 2012 · 17 citations · Full text

Medicine, Oncology, Pharmacology +16

Prophylactic Use of Oral Dexamethasone to Alleviate Fatigue During Regorafenib Treatment for Patients With Metastatic Colorectal Cancer

Shota Fukuoka, Kohei Shitara, Masaaki Noguchi et al. · Clinical Colorectal Cancer · 2016 · 17 citations

Medicine, Oncology, Pharmacology +11

Feasibility and Robustness of Amplification Refractory Mutation System (ARMS)-based KRAS Testing Using Clinically Available Formalin-fixed, Paraffin-embedded Samples of Colorectal Cancers

Naotaka Ogasawara, H. Bando, Yasuyuki Kawamoto et al. · Japanese Journal of Clinical Oncology · 2010 · 16 citations · Full text

Medicine, Oncology, Pathology +17

Clinical characterization of FGFR2b expression in patients with advanced gastric or gastroesophageal junction adenocarcinoma

Seiya Sato, Shannon Rhodes, Yu Aoki et al. · ESMO Open · 2025 · 10 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +16